Inhibitors of endocannabinoid breakdown for pain: Not so FA(AH)cile, after all

Pain

Volumn 153, Issue 9, 2012, Pages 1785-1786

  Di Marzo, Vincenzo ^a  

^a CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANANDAMIDE; CANNABINOID 1 RECEPTOR; DRONABINOL; ENDOCANNABINOID; FATTY ACID AMIDASE; FATTY ACID AMIDASE INHIBITOR; NAPROXEN; PF 04457845; PLACEBO; UNCLASSIFIED DRUG;

ANALGESIA; DRUG EFFICACY; DRUG TOLERABILITY; HUMAN; KNEE OSTEOARTHRITIS; KNEE PAIN; NONHUMAN; NOTE; PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 84864624995     PISSN: 03043959     EISSN: 18726623     Source Type: Journal    
DOI: 10.1016/j.pain.2012.06.016     Document Type: Editorial

References (14)

1. K. Ahn, S.E. Smith, M.B. Liimatta, D. Beidler, N. Sadagopan, D.T. Dudley, T. Young, P. Wren, Y. Zhang, S. Swaney, K. Van Becelaere, J.L. Blankman, D.K. Nomura, S.N. Bhattachar, C. Stiff, T.K. Nomanbhoy, E. Weerapana, D.S. Johnson, and B.F. Cravatt Mechanistic and pharmacological characterization of PF-04457845: a highly potent and selective fatty acid amide hydrolase inhibitor that reduces inflammatory and noninflammatory pain J Pharmacol Exp Ther 338 2011 114 124
2. F. Benedetti, M. Amanzio, R. Rosato, and C. Blanchard Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors Nat Med 17 2011 1228 1230
3. B. Costa, I. Bettoni, S. Petrosino, F. Comelli, G. Giagnoni, and V. Di Marzo The dual fatty acid amide hydrolase/TRPV1 blocker, N-arachidonoyl- serotonin, relieves carrageenan-induced inflammation and hyperalgesia in mice Pharmacol Res 61 2010 537 546
4. B.F. Cravatt, D.K. Giang, S.P. Mayfield, D.L. Boger, R.A. Lerner, and N.B. Gilula Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides Nature 384 1996 83 87
5. L. Gatta, F. Piscitelli, C. Giordano, S. Boccella, A. Lichtman, S. Maione, and V. Di Marzo Discovery of prostamide F2α and its role in inflammatory pain and dorsal horn nociceptive neuron hyperexcitability PLoS One 7 2012 1 12
6. Giordano C, Cristino L, Luongo L, Siniscalco D, Petrosino S, Piscitelli F, Marabese I, Gatta L, Rossi F, Imperatore R, Palazzo E, de Novellis V, Di Marzo V, Maione S. TRPV1-dependent and -independent alterations in the limbic cortex of neuropathic mice: impact on glial caspases and pain perception. Cereb Cortex, in press, http://dx.doi.org/10.1093/cercor/bhr328.
7. C.J. Hillard, K.M. Weinlander, and K.L. Stuhr Contributions of endocannabinoid signaling to psychiatric disorders in humans: genetic and biochemical evidence Neuroscience 204 2012 207 229
8. E.D. Högestätt, B.A. Jönsson, A. Ermund, D.A. Andersson, H. Björk, J.P. Alexander, B.F. Cravatt, A.I. Basbaum, and P.M. Zygmunt Conversion of acetaminophen to the bioactive N-acylphenolamine AM404 via fatty acid amide hydrolase-dependent arachidonic acid conjugation in the nervous system J Biol Chem 280 2005 31405 31412
9. J.P. Huggins, T.S. Smart, S. Langman, L. Taylor, and T. Young An efficient randomised, placebo-controlled clinical trial with the irreversible fatty acid amide hydrolase-1 inhibitor PF-04457845, which modulates endocannabinoids but fails to induce effective analgesia in patients with pain due to osteoarthritis of the knee PAIN® 153 2012 1837 1846
10. S. Petrosino, and V. Di Marzo FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels Curr Opin Investig Drugs 11 2010 51 62
11. Piscitelli F, Di Marzo V. "Redundancy" of endocannabinoid inactivation: new challenges and opportunities for pain control. ACS Chem Neurosci, in press, http://dx.doi.org/10.1021/cn300015x.
12. B.P. Roques, M.C. Fournié-Zaluski, and M. Wurm Inhibiting the breakdown of endogenous opioids and cannabinoids to alleviate pain Nat Rev Drug Discov 11 2012 292 310
13. R. Talwar, and V.K. Potluri Cannabinoid 1 (CB1) receptor-pharmacology, role in pain and recent developments in emerging CB1 agonists CNS Neurol Disord Drug Targets 10 2011 536 544
14. P.M. Zygmunt, J. Petersson, D.A. Andersson, H. Chuang, M. Sorgård, V. Di Marzo, D. Julius, and E.D. Högestätt Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide Nature 400 1999 452 457